CXCR4 and neoplasm: The ligand CXCL12 significantly increased in the CT-treated tumor and decreased with the combined treatment with Pep R. This could reflect an autocrine loop previously demonstrated in colon cancer cells in which the CXCR4-CXCL12 axis controls cell growth [22].